BeStock  
Stocks › Biotechnology › LKFT

Lakefront Biotherapeutics LKFT

US equityMarket cap rank #2629Biotechnology
$33.31 −$0.08 (-0.24%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $33.31 0.00%
Open$33.61
Prev close$33.39
Day range$33.25 – $33.85
Volume162.5K
Market cap$2.18B
P/E (TTM)2.5
Dividend yield–

LKFT Stock News

Headlines matching Lakefront Biotherapeutics or the LKFT ticker, most recent first.

  • RBC Capital Upgrades Lakefront Biotherapeutics(LKFT.US) to Buy Rating, Raises Target Price to $45 PositiveMarket news · 23 Sep 2026 · Direct mention
  • Morgan Stanley Upgrades Lakefront Biotherapeutics(LKFT.US) to Hold Rating, Raises Target Price to $30 PositiveMarket news · 3 Aug 2026 · Direct mention
  • Morgan Stanley Maintains Lakefront Biotherapeutics(LKFT.US) With Hold Rating, Maintains Target Price $30Market news · 10 Aug 2026 · Direct mention
  • Analysts Have Conflicting Sentiments on These Healthcare Companies: Lakefront Biotherapeutics (LKFT), Prime Medicine, Inc. (PRME) and Electrocore (ECOR)TipRanks · 10 Aug 2026 · Direct mention
  • RBC Capital Initiates Lakefront Biotherapeutics(LKFT.US) With Hold Rating, Announces Target Price $28Market news · 13 May 2026 · Direct mention
  • TD Cowen Initiates Lakefront Biotherapeutics(LKFT.US) With Buy RatingMarket news · 13 Nov 2026 · Direct mention
  • RBC Capital Maintains Lakefront Biotherapeutics(LKFT.US) With Buy Rating, Maintains Target Price $45Market news · 12 Nov 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on LKFT.

Sign in to join the discussion.

Scroll to Top